+351 211 369 829 INFO@OPHIOMICS.COM
Discussing translational research in Liver Cancer, in particular the role of SMEs in IVD development.
Ophiomics is now participating in the IPOready program by Euronext. This is a great opportunity to consider the best strategy
Ophiomics will be attending the ILTS-ILCA consensus conference in Valencia. This will be an excellent opportunity to get up to